Yes, that's his personal observation
"Inborn errors in the metabolism of glutathione"
e510 (2016)
Semaglutide and Tirzepatide mimic the hormones GLP-1 and GIP, which regulate blood sugar levels and appetite
Currently, there are ten classes of orally available pharmacological agents to treat T2DM: 1) sulfonylureas (SU), 2) meglitinides, 3) metformin (a biguanide), 4) thiazolidinediones (TZDs), 5) alpha glucosidase inhibitors, 6) dipeptidyl peptidase IV (DPP-4) inhibitors, 7) bile acid sequestrants, 8) dopamine agonists, 9) sodium-glucose transport protein 2 (SGLT2) inhibitors and 10) oral glucagon like peptide 1 (GLP-1) receptor agonists (6-8)
Copper-binding tripeptide research compound